Engineering immunotherapeutic probiotics to mitigate irAE
$43,377R01FY2021CANIH
Columbia Univ New York Morningside, New York NY
Investigators
Linked publications, trials & patents
Abstract
PROJECT SUMMARY/ABSTRACT No Changes
View original record on NIH RePORTER →